Close

Press Releases

CPhI South East Asia rescheduled for July 2020

CPhI South East Asia – organised by Informa Markets – has been rescheduled for the newly confirmed date of 1-3 July, 2020 at the IMPACT Centre in Bangkok, Thailand. The move from the original March 4-6 date was taken...

Iddi intensifies global debate on the future of randomized trials in Clinical Research

International Drug Development Institute (IDDI), a leading therapy-focused Biostatistics and eClinical Services corporation based in Belgium with offices in Boston (MA) and Raleigh (NC) announces that it is hosting a symposium to drive the debate: Are Randomized Clinical Trials...

Hyderabad all set to Host 17th Edition of BioAsia 2020, Asias largest Bio-Business Forum

The Telangana state is all set to host 2,000 delegates from 37 countries for 3-day BioAsia 2020, Asia’s largest Biotechnology and Life Sciences Forum to be inaugurated in Hyderabad on Monday, February 17, 2020. With the theme of ‘Today...

BioAsia 2020 Announces the Genome Valley Excellence Award to Dr. Carl H June & Dr. Vas Narasimhan

Asia's largest annual global Biotechnology and Life Sciences forum organized by the Government of Telangana, has announced that the prestigious Genome Valley Excellence Award will be bestowed upon Dr. Carl H June, CAR-T Cell Therapy Pioneer, Richard W. Vague...

Orgenesis completes sale of Masthercell subsidiary; receives approximately USD 127 million in net proceeds

Orgenesis Inc. , a provider of point-of-care cell and gene therapy development, processing and treatment solutions (“POCare”), announces the completion of the sale of its Masthercell Global, Inc. subsidiary, a contract development manufacturing organization (CDMO), to Catalent Pharma Solutions....

ACG Inspection Introduces Groundbreaking Blockchain-based Brand Platform

ACG Inspection–one of the four businesses of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry –has introduced an advanced blockchain-based solution that meets and exceeds traceability and anti-counterfeiting requirements in the...

BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501

BioXcel Therapeutics, Inc , a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to identify and advance the next wave of medicines in neuroscience and immuno-oncology, announced that its Investigational New Drug application for BXCL501, the Company’s proprietary sublingual thin-film...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read